107 related articles for article (PubMed ID: 28864268)
21. Baicalein inhibits nuclear factor-κB and apoptosis via c-FLIP and MAPK in D-GalN/LPS induced acute liver failure in murine models.
Wu YL; Lian LH; Wan Y; Nan JX
Chem Biol Interact; 2010 Dec; 188(3):526-34. PubMed ID: 20850421
[TBL] [Abstract][Full Text] [Related]
22. The role of the redox protein thioredoxin in cell growth and cancer.
Powis G; Mustacich D; Coon A
Free Radic Biol Med; 2000 Aug; 29(3-4):312-22. PubMed ID: 11035260
[TBL] [Abstract][Full Text] [Related]
23. Effects of arsenic trioxide under different administration ways on T-cell lymphoma xenografts in nude mice: in vivo and in vitro experiments.
Gao Y; Cai QQ; Li S; Bu Q; Liao H; Zhou Y; Huang HQ
Ai Zheng; 2009 Feb; 28(2):127-31. PubMed ID: 19550119
[TBL] [Abstract][Full Text] [Related]
24. The role of Ca2+ in baicalein-induced apoptosis in human breast MDA-MB-231 cancer cells through mitochondria- and caspase-3-dependent pathway.
Lee JH; Li YC; Ip SW; Hsu SC; Chang NW; Tang NY; Yu CS; Chou ST; Lin SS; Lino CC; Yang JS; Chung JG
Anticancer Res; 2008; 28(3A):1701-11. PubMed ID: 18630529
[TBL] [Abstract][Full Text] [Related]
25. Baicalein attenuates proteasome inhibition-induced apoptosis by suppressing the activation of the mitochondrial pathway and the caspase-8- and Bid-dependent pathways.
Jung EB; Lee CS
Eur J Pharmacol; 2014 May; 730():116-24. PubMed ID: 24631255
[TBL] [Abstract][Full Text] [Related]
26. A diterpenoid derivate compound targets selenocysteine of thioredoxin reductases and induces Bax/Bak-independent apoptosis.
Liu J; Mu C; Yue W; Li J; Ma B; Zhao L; Liu L; Chen Q; Yan C; Liu H; Hao X; Zhu Y
Free Radic Biol Med; 2013 Oct; 63():485-94. PubMed ID: 23732520
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of Radiation Response in Breast Cancer Stem Cells by Inhibition of Thioredoxin- and Glutathione-Dependent Metabolism.
Rodman SN; Spence JM; Ronnfeldt TJ; Zhu Y; Solst SR; O'Neill RA; Allen BG; Guan X; Spitz DR; Fath MA
Radiat Res; 2016 Oct; 186(4):385-395. PubMed ID: 27643875
[TBL] [Abstract][Full Text] [Related]
28. Preferential inhibition of hepatocellular carcinoma by the flavonoid Baicalein through blocking MEK-ERK signaling.
Liang RR; Zhang S; Qi JA; Wang ZD; Li J; Liu PJ; Huang C; Le XF; Yang J; Li ZF
Int J Oncol; 2012 Sep; 41(3):969-78. PubMed ID: 22684543
[TBL] [Abstract][Full Text] [Related]
29. Introduction of OX40 ligand into lymphoma cells elicits anti-lymphoma immunity in vivo.
Kaneko H; Hori T; Yanagita S; Kadowaki N; Uchiyama T
Exp Hematol; 2005 Mar; 33(3):336-43. PubMed ID: 15730857
[TBL] [Abstract][Full Text] [Related]
30. Sesamin promotes apoptosis and pyroptosis via autophagy to enhance antitumour effects on murine T-cell lymphoma.
Meng Z; Liu H; Zhang J; Zheng Z; Wang Z; Zhang L; Jia Z; Sui Y
J Pharmacol Sci; 2021 Nov; 147(3):260-270. PubMed ID: 34507635
[TBL] [Abstract][Full Text] [Related]
31. Properties and biological activities of thioredoxins.
Powis G; Montfort WR
Annu Rev Biophys Biomol Struct; 2001; 30():421-55. PubMed ID: 11441809
[TBL] [Abstract][Full Text] [Related]
32. Baicalein decreases side population proportion via inhibition of ABCG2 in multiple myeloma cell line RPMI 8226 in vitro.
Gu YY; Liu LP; Qin J; Zhang M; Chen Y; Wang D; Li Z; Tang JZ; Mo SL
Fitoterapia; 2014 Apr; 94():21-8. PubMed ID: 24468191
[TBL] [Abstract][Full Text] [Related]
33. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
[TBL] [Abstract][Full Text] [Related]
34. [Study of the immunological mechanism of anti-tumor effects of 5-FU by establishing EL4 tumor-bearing mouse models].
Li ML; Li CG; Shu XH; Li MX; Jia YJ; Qin ZH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Nov; 23(11):1010-3. PubMed ID: 17988579
[TBL] [Abstract][Full Text] [Related]
35. ASK1/JNK-mediated TAp63 activation controls the cell survival signal of baicalein-treated EBV-transformed B cells.
Park GB; Kim YS; Lee HK; Yang JW; Kim D; Hur DY
Mol Cell Biochem; 2016 Jan; 412(1-2):247-58. PubMed ID: 26694167
[TBL] [Abstract][Full Text] [Related]
36. Properties and biological activities of thioredoxins.
Powis G; Montfort WR
Annu Rev Pharmacol Toxicol; 2001; 41():261-95. PubMed ID: 11264458
[TBL] [Abstract][Full Text] [Related]
37. Baicalein protects against polymicrobial sepsis-induced liver injury via inhibition of inflammation and apoptosis in mice.
Liu A; Wang W; Fang H; Yang Y; Jiang X; Liu S; Hu J; Hu Q; Dahmen U; Dirsch O
Eur J Pharmacol; 2015 Feb; 748():45-53. PubMed ID: 25533331
[TBL] [Abstract][Full Text] [Related]
38. Baicalein inhibits prostate cancer cell growth and metastasis via the caveolin-1/AKT/mTOR pathway.
Guo Z; Hu X; Xing Z; Xing R; Lv R; Cheng X; Su J; Zhou Z; Xu Z; Nilsson S; Liu Z
Mol Cell Biochem; 2015 Aug; 406(1-2):111-9. PubMed ID: 25957503
[TBL] [Abstract][Full Text] [Related]
39. Inactivation of the small GTP binding protein Rho induces multinucleate cell formation and apoptosis in murine T lymphoma EL4.
Moorman JP; Bobak DA; Hahn CS
J Immunol; 1996 Jun; 156(11):4146-53. PubMed ID: 8666781
[TBL] [Abstract][Full Text] [Related]
40. In vivo and in vitro effect of baicalein on human prostate cancer cells.
Miocinovic R; McCabe NP; Keck RW; Jankun J; Hampton JA; Selman SH
Int J Oncol; 2005 Jan; 26(1):241-6. PubMed ID: 15586246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
